euro adhoc: Clariant International Ltd.
Annual Reports
Clariant
Post Profit, Announces Major
Job Cuts and Plans Capital Increase (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
MUTTENZ, Switzerland - Feb. 24, 2004 -- Clariant AG showed a resilient performance amid tough market conditions in 2003, posting a 1% rise in turnover measured in local currency terms and holding margins steady. The company recorded a net profit of CHF 161 million and substantially reduced net debt, to CHF 2.9 billion.
At the same time, Clariant announced that its Transformation Program is well on-track. The asset sales process is proceeding according to schedule, including the sale of Electronic Materials, in which negotiations are well advanced. The Transformation Program will result in the company eliminating 4,000 jobs over the next two years.
Clariant also announced that the Board of Directors will propose at the Annual General Meeting on April 2nd a capital increase amounting to approximately CHF 920 million.
Positive Results in a Difficult Environment
For the year ending Dec. 31, 2003, sales totaled CHF 8.5 billion in local currency terms, up 1% compared to 2002. In Swiss franc terms, sales were down 3% from a year earlier. Net profit for the year was CHF 161 million compared to a net loss of CHF 648 million in 2002.
Four of Clariants five divisions recorded sales gains in local currency terms, with Life Sciences & Electronic Chemicals being the exception.
Measures initiated in 2003 improved working capital management, resulting in significantly improved cash flow in the second half of the year.
Net debt was reduced from CHF 3.7 billion in the middle of the year to CHF 2.9 billion by year-end. Shareholders equity increased by CHF 200 million to total approximately CHF 1.2 billion, lifting the equity ratio to approximately 15%. The Board of Directors will propose a gross dividend of CHF 0.20 per share.
"Our efforts to improve the companys results have paid off, but we still have a lot of work ahead of us," said Clariant Chief Executive Roland Loesser.
Transformation Program On-Track
In mid 2003, Clariant initiated a Transformation Program designed to create a substantially more competitive company. It includes the sale of non-core assets as well as a wide range of measures to improve performance.
The sale of the Cellulose Ethers business unit was successfully completed at the end of 2003. Negotiations to sell Electronic Materials are well advanced. In addition, two other units are now ready for sale.
Clariant successfully implemented projects to improve efficiency in the areas of purchasing, logistics and production in selected parts of the company in the second half of 2003 and these will now be extended throughout the group. In addition, measures to improve the efficiency of the organizational structure and of business processes will lead to the reduction of 4,000 jobs worldwide over the next two years. The main areas affected are general administration, infrastructure, production and the supply chain. The areas of sales and client service will be unaffected. Various functions previously carried out elsewhere will henceforth be concentrated in the Muttenz headquarters.
"These jobs cuts are painful, but unfortunately they are unavoidable given the need to ensure Clariants long-term strength," Mr. Loesser said. "We must be highly efficient in all our operations in order to retain a competitive advantage."
Capital Increase Planned
Clariants Board will propose at the next Annual General Meeting a capital increase of approximately CHF 920 million. The requested capital increase is fully underwritten by a banking syndicate led by Citigroup and UBS.
"The capital increase is aimed at strengthening our balance sheet and therefore the long-term competitiveness of the company," Mr. Loesser said. "It will facilitate the execution of the Transformation Program and give the business greater flexibility."
Board Changes Long-time board member Pierre Borgeaud has reached the statutory retirement age and will step down from the Board at the next meeting. Two new members have been proposed: The Swiss lawyer Peter R. Isler, a partner at the Zurich law firm Niederer, Kraft & Frey and the Frankfurt-based businessman Dr. Kajo Neukirchen.
Outlook Regarding the current business year, Mr. Loesser said: "For the time being, I do not see a sustainable improvement in demand, but I am more optimistic than three months ago. I am off course even more positive about Clariant given the measures we have put in place." In addition, Mr. Loesser confirmed the companys target, announced in August 2003, to achieve CHF 100 million in cost savings this year, deliver an EBIT improvement of CHF 400 million within the next three years and reduce working capital by CHF 600 million over the same period.
The main terms of the Capital Increase are as follows
Issuance of up to 92 064 000 fully paid registered shares representing aggregate proceeds of approx. CHF 920 million.
the issued shares will be entitled to dividends for the 2004 financial year. the detailed terms will be announced at the AGM of April 2, 2004.
The pre-emptive rights (Bezugsrechte) of existing shareholders shall be granted. They shall be traded between April 13, 2004 and April 20, 2004 and shall be exercisable from April 13, 2004 until noon CET on April 21, 2004.
Pre-emptive rights not exercised during the exercise period shall be placed or taken up by the underwriting syndicate.
Resumes of Proposed New Board Members
Dr. Peter R. Isler, born in 1946, studied law at the universities of Zurich and Harvard. Since 1977 he has been with the law firm Niederer Kraft & Frey, becoming a partner in 1981. Dr. Isler also teaches trade and commercial law at the University of Zurich.
Dr. Kajo Neukirchen, born in 1941, studied physics and economics. He served as chief executive of several German corporations, most recently at Metallgesellschaft (now MG Technologies), a specialty chemical, building technologies and machinery group.
Key Financial Group Figures 2003 (in CHF mn) like-for-like
~
Full Year 2003 2002 Change %
(like-for-like) 2003 compared
with 2002
(like-for-like)
CHF LC
Sales 8516 8824 -3 +1
Gross profit 2729 2898 -6 -3
Margin 32% 32.8%
EBITDA 1119 1125
Margin 13.1% 12.7% -1 +5
EBIT before
restructuring,
impairment,
disposals and
amortisation
of goodwill 611 640
Margin 7.2% 7.3% - -
EBIT 559 -250
Margin 6.6% - - -
Net income 161 -693 - -as per Dec. 02 June 03 Dec. 03 Net debt 3476 3686 2905 Equity 914 1061 1176
4th quarter 2003 2002 Change %
(like-for-like)1 2003 compared with
2002 (like-for-like) 1
CHF
Sales 2114 2097 +1
Gross profit 667 635
Margin 31.6% 30.3% +5
EBITDA 423 290
Margin 20.0% 13.8% +46
EBIT before
restructuring,
impairment and
disposals 98 -702
Margin 4.6% -
EBIT 262 -721 -
Margin 12.4%
Net income 172 -835 -
~1 The numbers for 2002 were like-for-like to account for the disposals of business activities in 2002. Disposals in 2002: Emulsion business of Division Textile, Leather and Paper. Hydrosulfite business in North America of Division Textile, Leather and Paper. Emulsion businesses Portugal of Division Textile, Leather and Paper. All activities were sold effective as per the end of 2002.
Calendar of Corporate Events
April 2, 2004 Annual General Meeting April 7, 2004 Ex-Dividend Date May 4, 2004 First Quarter 2004 Results August 5, 2004 First Half Year 2004 Results November 9, 2004 Third Quarter 2004 Results
Your Clariant Contacts
Media Relations
Christoph Hafner Tel. +41 61 469 67 46 Rainer Weihofen Tel. +41 61 469 67 42 Fax +41 61 469 65 66
Investor Relations Tel. +41 61 469 67 48 Fax +41 61 469 67 67 Holger Schimanke Tel. +41 61 469 67 45 Daniel Leuthardt Tel. +41 61 469 67 49
Clariant - Exactly your chemistry.
Clariant is a global leader in the field of specialty chemicals. Strong business relationships, commitment to outstanding service and wide-ranging application know-how make Clariant a preferred partner for its customers.
Clariant, which is represented on five continents with over 100 group companies, employs about 27,000 people. Headquartered in Muttenz near Basel, it generated sales of around CHF 8.5 billion in 2003.
Clariants businesses are organized in five divisions: Textile, Leather & Paper Chemicals, Pigments & Additives, Masterbatches, Functional Chemicals and Life Science & Electronic Chemicals.
Clariants innovative products play a key role in its customers manufacturing and treatment processes or else add value to their end products. The companys success is based on the know-how of its people and their ability to identify new customer needs at an early stage and to work together with customers to develop innovative, efficient solutions.
Clariant is committed to sustainable growth springing from its own innovative strength. Our objective is to generate 30% of sales with products and services that are no more than five years old.
www.clariant.com
end of announcement euro adhoc 24.02.2004
Further inquiry note:
Media Relations
Christoph Hafner Tel. +41 61 469 67 46
Rainer Weihofen Tel. +41 61 469 67 42
Fax +41 61 469 65 66
Investor Relations Tel. +41 61 469 67 48
Fax +41 61 469 67 67
Holger Schimanke Tel. +41 61 469 67 45
Daniel Leuthardt Tel. +41 61 469 67 49
Branche: Chemicals
ISIN: CH0012142631
WKN:
Index: General Standard, SMI
Börsen: Frankfurter Wertpapierbörse / official dealing
SWX Swiss Exchange / official dealing
Berliner Wertpapierbörse / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade
Börse Düsseldorf / free trade
Baden-Württembergische Wertpapierbörse / free trade